REMINDER: Our user survey closes on Friday, please submit your responses here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksThalassa (di) Regulatory News (THAL)

Share Price Information for Thalassa (di) (THAL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 24.50
Bid: 23.00
Ask: 26.00
Change: 0.00 (0.00%)
Spread: 3.00 (13.043%)
Open: 24.50
High: 24.50
Low: 24.50
Prev. Close: 24.50
THAL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Share Dealings

8 Jan 2014 15:15

RNS Number : 2171X
Thalassa Holdings Limited
08 January 2014
 



8 January 2014

 

Thalassa Holdings Ltd

 

(Reuters: THAL.L, Bloomberg: THAL:LN)

 

("Thalassa" or the "Company")

 

Transaction in own Shares, Director's Sale and Related Party Transactions

 

 

The Board reported on 8 January 2014 Thalassa's continuing strong performance in 2013, which the Board largely attributes to the performance of its employees and consultants. The Board is therefore keen to promote a programme of management share ownership so as to incentivise and reward these individuals on a long term basis for the benefit of all shareholders.

 

The Board is therefore pleased to announce that Duncan Soukup, the Company's Chairman, has agreed today to sell 1,000,000 shares of $0.01 each of the Company ("Ordinary Shares") to the THAL Discretionary Trust at a price of £2.70 per share. Following the sale Mr Soukup will be interested in 3,112,571 Ordinary Shares.

 

The Board also announces that the Company has also agreed today to sell 1,078,667 Ordinary Shares to the THAL Discretionary Trust out of treasury at a price of £0.264 per Ordinary Share.

 

Upon completion of these sales, the THAL Discretionary Trust, which holds the shares for the benefit of the Company's employees, directors and consultants, will be interested in a total of 3,078,667 Ordinary Shares.

 

Following the sale of the Ordinary Shares in treasury, the Company's issued share capital will comprise 25,057,522 Ordinary Shares, with no further Ordinary Shares held in treasury.

 

To finance these purchases by the THAL Discretionary Trust, the Company has agreed to provide a loan of £3,054,768 to the THAL Discretionary Trust. The loan, which has been granted for a term of up to 36 months, bears interest annually at Base Rate plus 3 per cent.

 

The purchase of the 1,078,667 Ordinary Shares from the Company's treasury and the £3,054,768 loan from the Company to the Trust both represent related party transactions under AIM Rule 14. The Directors of the Company, other than Mr Soukup who is a trustee of the Trust, (the "Independent Directors") having consulted with the Company's nominated adviser, consider that the terms of these transactions are fair and reasonable insofar as the Company's shareholders are concerned. In reaching this conclusion, the Independent Directors viewed the sale of the shares from treasury at a price of £0.264 each, compared to a closing price on 7 January 2014 of £2.875, as being broadly akin to an award of free shares under a long term incentive plan to compensate these individuals for their relatively low levels of remuneration and equity participation whilst the Thalassa business has developed over recent years, and to incentivise and reward such individuals on a long term basis for the benefit of all shareholders.

 

 

Duncan Soukup, Chairman, said: "On a personal level, I have agreed to sell 1,000,000 shares, the benefit which will, over time, inure to employees and contractors deemed to be key to the future growth of the Company. This is part of a programme to increase employee ownership in the Company and is the first time in 5 years that I have sold shares. Having acquired 447,750 shares at the placing in April 2013, this sale therefore only represents a net sale of 552,250 shares, which equates to less than 100,000 shares on average per year since admission in July 2008. I have no intention to sell any further shares for the foreseeable future and certainly not the next 12 months."

Contacts:

Thalassa Holdings Ltd:

 

Duncan Soukup, Executive Chairman +33 (0)6 78 63 26 89

WH Ireland Limited (Nominated adviser):

Chris Fielding, Head of Corporate Finance 020 7220 1650

www.thalassaholdingsltd.com

 

Notes to Editor:

 

Thalassa Holdings Ltd, incorporated and registered in the BVI and quoted on AIM, is a holding company with a focus on marine seismic operations. The corporate strategy for the Group is "Exploration and Beyond". "Exploration" is focused on activity in frontier and challenging locations, whilst "Beyond" focuses on production activity by looking to secure opportunities in the permanent reservoir monitoring market. Thus activity and focus will be dominated by projects in remote and challenging frontier locations, coupled with lower risk projects in mature producing regions.

 

Alongside the technical expertise and consultancy in marine seismic operations provided through its subsidiary, WGP, the Group operates three portable modular source systems (PMSS™). The PMSS™ generates a seismic source for use in seismic acquisition in petroleum exploration and production. The equipment is temporarily installed on the back of a platform supply vessel for the purposes of acquiring data.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCUWRVRSNAARAR
Date   Source Headline
30th Apr 20243:40 pmEQSThalassa Holdings Ltd:
30th Apr 20243:33 pmEQSThalassa Holdings Ltd: Annual Financial Report
12th Jan 20247:36 amEQSThalassa Holdings Ltd: Trading Update
16th Nov 202312:27 pmEQSThalassa Holdings Ltd: TR1
29th Sep 20239:01 amEQSThalassa Holdings Ltd: Interim Results (30 June 2023)
28th Sep 202311:09 pmEQSThalassa Holdings Ltd: Amendment to Articles of Association
17th Jul 20238:12 amEQSThalassa Holdings Ltd: Restoration of Listing
10th Jul 202310:50 amEQSThalassa Holdings Ltd: Final Results For Year Ended 31 December 2022
30th Jun 20237:57 pmEQSThalassa Holdings Ltd: Result of AGM
7th Jun 20237:51 pmEQSThalassa Holdings Ltd: AGM Proxy Form
5th Jun 202311:20 amEQSThalassa Holdings Ltd: Notice of AGM
2nd May 20237:51 amEQSThalassa Holdings Ltd: Temporary Suspension
2nd May 20237:30 amRNSSuspension - Thalassa Holdings Ltd
19th Apr 20238:45 pmEQSAppointment of Auditor
14th Feb 20234:12 pmEQSThalassa Holdings Ltd: Confirmation of previously announced proposal
27th Jan 20233:40 pmEQSThalassa Holdings Ltd: Trading Statement
27th Jan 20232:40 pmEQSThalassa Holdings Ltd: Trading Statement
13th Dec 20227:38 pmEQSThalassa Holdings Ltd: STR-Statement re resignation of auditor
13th Dec 20226:38 pmEQSThalassa Holdings Ltd: STR-Statement re resignation of auditor
24th Oct 20228:35 amEQSThalassa Holdings Ltd: Correction
24th Oct 20228:34 amEQSThalassa Holdings Ltd: Correction
21st Oct 202211:00 amEQSThalassa Holdings Ltd: Directorate Change
21st Oct 202210:59 amEQSThalassa Holdings Ltd: Directorate Change
15th Aug 20227:01 amEQSThalassa Holdings Ltd: Interim Results
15th Aug 20227:00 amEQSThalassa Holdings Ltd: Interim Results
28th Jun 20223:47 pmEQSThalassa Holdings Ltd: Result of AGM
28th Jun 20223:47 pmEQSThalassa Holdings Ltd: Result of AGM
27th Jun 20221:03 pmEQSThalassa Holdings Ltd: Appointment of Broker
27th Jun 20221:02 pmEQSThalassa Holdings Ltd: Appointment of Broker
9th Jun 20223:37 pmEQSThalassa Holdings Ltd: Final Results for Year Ended 31 December 2021
9th Jun 20223:34 pmEQSThalassa Holdings Ltd: Final Results for Year Ended 31 December 2021
9th Jun 20223:19 pmEQSThalassa Holdings Ltd: Notice of AGM
9th Jun 20223:18 pmEQSThalassa Holdings Ltd: Notice of AGM
24th May 202211:27 amEQSThalassa Holdings Ltd: Appointment of Non-Executive Director
28th Feb 20221:37 pmEQSThalassa Holdings Ltd: Trading Statement
17th Dec 20217:17 amRNSReverse Takeover of id4 AG by Anemoi International
15th Nov 20219:01 amRNSid4 delivers Client Space solution
28th Oct 20215:00 pmRNSHolding(s) in Company
7th Oct 20213:59 pmRNSResult of AGM
28th Sep 20217:00 amRNSInterim Results
17th Sep 202112:50 pmRNSLondon Medical Laboratory investment update
30th Jul 20213:23 pmRNSProposed Transaction
22nd Jun 202110:29 amRNSFinal Results for YE 31 Dec 2020 and Notice of AGM
14th Jun 20217:00 amRNSPreliminary Results for the year ended 31 Dec 20
29th Apr 20217:01 amRNSGrant Funded Project for Autonomous Robotics Ltd
29th Apr 20217:00 amRNSNotice of Results
8th Mar 20217:00 amRNSDe-listing from Luxembourg Stock Exchange
3rd Mar 20217:00 amRNSAppointment of Chief Financial Officer
4th Feb 202111:17 amRNSThalassa subsidiary id4 wins at Swiss WB Awards
2nd Feb 20217:00 amRNSInvestment in London Medical Laboratory Limited

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.